Equity Incentive Plans (Tables)

12 Months Ended

Dec. 31, 2025

Equity Incentive Plans

Schedule of Stock Option Activity

	Options Outstanding
				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
		Exercise		Term	Intrinsic
	Shares	Price		(Years)	Value (in thousands)
Outstanding at December 31, 2024	3,755,965	$	3.74	7.5	$	4
Granted	1,596,058	$	2.04		$	—
Exercised	(201,602)	$	3.26		$	953
Forfeited/Cancelled/Expired	(346,500)	$	3.38		$	31
Outstanding at December 31, 2025	4,803,921	$	3.22	7.4	$	15,045
Vested and expected to vest at December 31, 2025	4,803,921	$	3.22	7.4	$	15,045
Exercisable at December 31, 2025	2,294,337	$	3.94	6.0	$	5,728

Schedule of restricted stock awards

		Weighted Avg
		Grant Date
	Shares	Fair Value
Outstanding at December 31, 2024	220,000	$	2.73
Granted	—	$	—
Vested	(67,500)	$	2.65
Cancelled	—	$	—
Outstanding at December 31, 2025	152,500	$	2.73

Schedule of Assumptions Used in the Black-Scholes Model

	Year Ended December 31,
	2025	2024
Risk-free interest rate	4.22%-4.28%	3.54%-4.25%
Expected volatility	99.64%-101.43%	89.40%-92.50%
Expected term (in years)	5.5-7.0	5.1-7.0
Expected dividend yield	0%	0%

Schedule of Stock-Based Compensation Expenses

The table below summarizes the total stock-based compensation expense included in the Company’s consolidated statements of operations for the periods presented (in thousands):

	Year Ended December 31,
	2025		2024
Research and development	$	999	$	663
General and administrative		1,611		2,230
Total stock-based compensation	$	2,610	$	2,893